Skip to content

Immediate Nausea and Vomiting After the Administration of Non-ionic Contrast Media

Immediate Nausea and Vomiting After the Administration of Non-ionic Contrast Media: Prevalence and Risk Factors

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03019341
Enrollment
1175
Registered
2017-01-12
Start date
2017-01-01
Completion date
2017-03-31
Last updated
2017-04-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Contrast Agent, Nausea

Keywords

Nausea, Vomiting, Non-ionic contrast media, Side effect

Brief summary

The prevalence of nausea and vomiting after the administration of non-ionic contrast media has rarely been assessed. Thus, the aim of our study is to evaluate the prevalence and risk factors of nausea and vomiting after the exposure to the non-ionic contrast media for computed tomography examinations in adults.

Detailed description

There is no robust evidence or guideline for fasting prior to contrast-enhanced CT scan in patients. Substantial heterogeneity exists on fasting prior to contrast-enhanced CT worldwide. Through dedicated questionnaires, the investigators plan to prospectively assess the prevalence and the risk factors for nausea and vomiting after the exposure to the non-ionic contrast media agent in adult patients undergoing computed tomography examinations.

Interventions

None listed

Sponsors

Seoul National University Hospital
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
20 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients undergoing contrast-enhanced CT examination with non-ionic contrast media during regular working hours * Adult patients (20 years old or older) * Patients with informed written consent * Patients under observation by medical staffs during and after CT examination up to 30 minutes.

Exclusion criteria

* Patients without informed written consent * Age of patients younger than 20 years old * Uncooperative patients * Pediatric, pregnant, and emergent patients * Patients without sufficient observation by medical staffs during and after CT examination up to 30 minutes.

Design outcomes

Primary

MeasureTime frameDescription
Prevalence of immediate nausea or vomiting after contrast injectionFor 30 minutes after administration of non-ionic contrast mediaPatients will be observed for 30 minutes after the administration of the contrast media agent and medical staffs will record and evaluate the patients' status and the severity of gastrointestinal reaction to the contrast media agent such as nausea or vomiting.

Countries

South Korea

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026